Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × cediranib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Fallopian Tube Neoplasms 6 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Gliosarcoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uveal Melanoma 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡